BiotechIndustryStocks.com Portal is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.

Submit Biotech and Pharma news : click here. News will be featured on up to 3 sector portals and the Investor Ideas Newswire .

Biotechnology.com News

• Allon Therapeutics human efficacy data to be featured at world’s leading Alzheimer's disease conference - click here
• Allon completes dosing in Phase II cognitive impairment trial - click here
• Meridian Signs Agreement in Principle to Acquire Line of Recombinant Proteins from Vybion, Inc. - click here
• Millipore Announces Major, Multi-Year Environmental Effort - click here
• President Bush is Right on Biofuels - click here

Click Here For More

Biotechnology Research and Articles

• RNCOS Releases a New Report- Booming Biotech Market in India - Click Here
• Economic Growth, Improving Medical Infrastructure Backing E7 Pharma Markets - Click Here
• Point of Care Diagnostics to Chip in 34% in Global IVD Market - Click Here
• Economical Cure - Generics to Penetrate 26% Pharma Market in Canada - Click Here
• RNCOS Releases a New Report-Global In Vitro Diagnostic Market Analysis - Click Here

Click Here For More

Biotech Research and Articles

• Research and Markets: Bio Ethanol and Bio Pharmaceuticals Industries Prop up the U.S. Industrial Enzymes Market - click here
• RNCOS Releases a New Report- Emerging Pharmaceutical Markets Globally - click here
• VICTHOM HUMAN BIONICS INC. (TSX:VHB) - RECENT DEVELOPMENTS: F2007 RESULTS; INTERIM PRESIDENT NAMED - click here
• The US biotech market has been experiencing diverse changes for the past few years, but despite these changes, it is only booming - click here
• Indian Biotechnology Market Outlook (2006) - India is fast becoming one of the most favored global destinations for biotechnology - click here

Biotech RSS Feeds

• 3M completes acquisition of IMTEC Corp. ()  3M announced that it has completed its acquisition of IMTEC Corp., a manufacturer of dental implants and cone beam computed tomography (CBCT) scanning equipment for dental and medical radiology ...
• Dr. Bernd Burkhart appointed head of BASF's Aroma Chemicals business ()  Effective as from June 1, 2008, Dr. Bernd Burkhart is the new head of BASF Aroma Chemicals business. He succeeds Dr. Ulrich Schaefer-Luederssen, who died unexpectedly in April earlier this year.Dr. ...
• INEOS and The Carlyle Group complete the agreement to combine INEOS Silicas and PQ Corporation ()  Following clearance by the competition authorities, INEOS has completed the agreement to combine INEOS Silicas and PQ Corporation, the speciality chemical company owned by The Carlyle Group. The ...

• Capella University - Sponsored Link (Fri, 4 Jul 2008 01:44:00 GMT)  Ad - Explore over 80 master's and doctoral specializations. Accredited.
• Software Firm Focuses On Not-So-Blind Dates; It Unites Science, Pharma; J&J, other big drug makers see need for better ways to seek out research labs (Fri, 4 Jul 2008 01:44:00 GMT)   words PETER BENESH Think of IdeaPoint as an online matchmaker bringing biotech inventors and biopharma companies together.In one corner, toiling away in academic labs and small biotech firms, are thousands of inventive scientists eager to put their
• Abbott granted approval for Xience V drug eluting stent (Fri, 4 Jul 2008 01:37:00 GMT)  The Xience V drug coated stent is used to treat coronary artery disease by propping open a narrowed or blocked artery and releasing the drug, everolimus, in a controlled manner to prevent the artery from becoming blocked again following a stent

Biotech News Feeds

• DSM joins select “Pathfinders” and attains Carbon Trust Standard Certification (Fri, 27 Jun 2008 12:02:26 GMT)  Royal DSM N.V. creates innovative products and services in life sciences and material sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. DSM has annual sales of almost 8.8 billion euro's and employs some 23,000 people worldwide. The company's headquarter's are situated in the Netherlands, with locations on five continents. The Carbon Trust is an independent company set up by the government in response to the threat of climate change, accelerating the move towards a low carbon economy by working with organisations to reduce carbon emissions and develop commercial low carbon technologies. The Carbon Trust works with UK businesses and the public sector through its work in five complementary areas: insights, solutions, innovations, enterprises and investments. Together these help to explain, deliver, develop, create and finance low carbon enterprise. The Carbon Trust is funded by the Department for Environment, Food and Rural Affairs (Defra), the Department for Business, Enterprise and Regulatory Reform (BERR), the Scottish Government, the Welsh Assembly Government and Invest
• Aesica Appoints Michael Staff Vice President, Sales & Business Development, North America (Thu, 26 Jun 2008 18:22:37 GMT)  Aesica, a leading supplier of active pharmaceutical ingredients and formulated products to the global pharmaceutical industry, announces the appointment of Michael Staff as Vice President, Sales and Business Development, North America. Michael joins Aesica from Minakem, a French fine chemical company, where he was President and CEO of their US subsidiary. During his seven years at the company, Michael established Minakem's US operations and was responsible for all legal and corporate aspects of the business including profitability and personnel. Michael was the main driving force behind the significant growth of Minakem's US market sales. Prior to Minakem, Michael was at Yamakawa Chemical Industry where he was manager of the New York office and Mitsubishi International Corporation where he held the position of Manager, Business Development. At Aesica, Michael will be responsible for developing and building Aesica's presence in North America through the establishment of a US subsidiary. His appointment marks the establishment of Aesica's commercial presence in North America and affirms Aesica's commitment to becoming the number one supplier of APIs and formulated products to the global pharmaceutical market. The new North America office will help strengthen Aesica's expanding operations in the United States and Canada by providing access to a diverse set of customers while also supporting the Company's existing international business and operations. Michael will be based in New Jersey and will report to Alan Raymond, Aesica's Commercial Director. Alan Raymond said: "Aesica has always understood the importance of the North American market which today accounts for the majority of our overall sales. Michael's excellent track record in pharmaceutical manufacturing and knowledge of the North American market, together with the establishment of our New Jersey office, will allow us to grow further from what is already a solid base." Michael Staff said: "Aesica is a fast growing company with an entrepreneurial spirit backed by world-class facilities, technologies and customer service. I'm delighted to be joining the Company and look forward to working with the senior team in taking this transforming step forward to expand Aesica's North American presence and business."
• Honeywell and Loba Chemie Sign Distribution Agreement for Laboratory Chemicals in India (Thu, 26 Jun 2008 17:02:35 GMT)  Honeywell (NYSE:HON) announced today a multi-year distribution agreement with Loba Chemie, a global supplier of chemicals, laboratory supplies and equipment, under which Loba Chemie will distribute Honeywell's high-purity solvents to India's growing pharmaceutical sector. Marketed and sold under the Burdick & Jackson® brand name, Honeywell's high-purity solvents are critical to the successful research, development and approval cycle of pharmaceuticals. Terms of the agreement were not disclosed. "India is an important market for us as the pharmaceutical industry continues to experience tremendous growth," said Robert Tupker, commercial director for Honeywell's Specialty Chemicals business in Europe, Middle East, Africa and India. "This agreement will further help position us as a leader in providing a wide range of high-purity solvents for pharmaceutical companies worldwide." Vic Shah, director international sales for Loba Chemie, said both companies aim to reach a new standard of success in the high-quality chemicals market in India. "We believe there are a lot of untapped opportunities to be explored, especially in the booming pharmaceutical industry," said Shah. The annual growth rate of India's pharmaceutical market is estimated to be 8% to 9%, according to various industry reports. Major applications for Honeywell's solvents include analytical instrumental analysis, such as high-performance liquid chromatography (HPLC), as well as pilot and full scale production of pharmaceuticals. Honeywell also offers reagents for DNA and RNA synthesis.

Biotech News and Research Resources

• About Biotech - Discusses issues, careers, and other topics. From Genentech.
• Academic Info: Biotechnology - A directory of Internet resources for the study of biotechnology.
• Bio.com - The editorial focus is on the technology of the life sciences.
• Bio Drug Technology - Contains links to organizations, publications, career information and news about projects in the field.
• Bio Supply Net - Searchable database of biotechnology products and companies that supply them. Includes contact information.
• Bio Track - Focuses on information related to the regulatory oversight of biotechnology derived products.
• Bio Wisdom - Database of research and development news in the biopharmaceutical field. Must sign up to use.
• BioExchange.com - Portal for biochemistry, cell biology, cloning, proteomics, biopharmaceuticals and related sciences. Features industry news, protocal information, careers, books, available software and an online market.
• Biophysics ORG - European Federation of Biophysics
• BiomedicalStocks.com - Free information on biomedical stocks (such as biotech, pharmaceutical and medical device firms).
• Bioscience Technology 
• Biotech Browser - Database software (running on Windows) that includes listings of companies, clinical trials, products and services related to the field. Includes information about different features offered in the package. Requires a subscription fee.
• Biotech Directory  
• Biotech Find - Searchable database listings for companies, universities, and events. Includes featured articles, industry news and suggested book readings.
• Biotech Insight - A stock letter for biotechnology investors.
• Biotech Ontario - Resource for biotechnology information, including companies, biomedical and genomic research, incubation, venture capital and technology transfer.
• BioTech Professional Resources - Portal includes links to careers, research facility programs, organizations, regulations, events, and companies related to the field. Compiled by Indiana University.
• Biotech Media - Contains glossary of terms. Includes database of products and services with corresponding print materials for purchase or subscription.
• Biotech News - News breakthroughs & innovations.
• Biotech Resource - Portal of companies, tutorials, and information sites. From the University of New Mexico.
• Biotech Support Services - Information about companies, research institutes, educational facilities, journals, suppliers, software, literature, resources, and government facilities.
• Biotechnology 101
  Advice on researching and investing in biotech companies from Biotech Navigator
• Biotechnology Research Tools - Database of pages covering various topics in the field. Selected by bioscientists.
• Biotechnology Resources on the Internet 
  Searchable database of government regulatory pages, biomedical, bioinformatics, chemical engineering and other related links.
• Biotechnology Information Resource Includes links to webpages and publications that focus on genetically modified crops and animals, as well as environmental safety.
• BiotechWatch.com - Information on publicly trade companies.
• BioCentury - Business intelligence.
• Biospace.com - An aggregation of news, information, and services for those who work and invest in the biotechnology and pharmaceutical industries.
• BioWorld - Online  News & Information Source
• Biotaq.com - News & new products.
• biotech.equityresearchcenter.com/
• Biospace Movers Page
  Keep track of the most actives, losers, and gainers in Biotech/Biomedicine. Links include mutual funds, clinical trial news, and regional hotbeds.
• Bull Market Biotech Investor  
  Is a FREE publication that focuses on the changing Biotech and Pharmaceutical world we live in and the companies that are going to profit from these changes. 
• Clinical trial listing service
• Facts Online Investment, merger, acquisition, and income information on private and public technology-based companies.
• Hardin MD - Selected lists of internet sources in biotechnology, molecular, biology, genetics. From the University of Iowa.
• Independent Biotech Consultancy Services - Our biotech consultants provide independent investment advice and consultation to clients interested in investing in the biotechnology, life sciences and pharmaceutical industries
• International biotechnology resources
• InvestBio - Biotech Investing Tactics and Research
  Take advantage of the most powerful investment sector, biotechnology. Receive unbiased investment information, research, news, and reports on which stocks to buy or sell in the biotechnology sector.
• IPOs Inflate Stock Prices
  Article showing how spinning off Genentech instantly raised its value from $11 billion to $16 billion.
• links/index.php?ParentID=283 
• Long Term Care Insurance Free Comparison Quotes and Research Center - Tips, tools, traps and tricks exposed for winning the insurance
  game now. Trusted public service decision assistance thru Buyers Advocates sponsored by the National Advisory Council since 1995.
• Long Term Care Insurance Rate Reporter - Insider Secrets - Long term care insurance strategies, companies & rates compared as a public service for buyers. Personal guidance sponsored by the National Advisory Council's Buyers Advocate Outreach.
• Med Web Plus - Biotechnology - Searchable database of genetics, microbiology, companies, associations and resource links.
• NASDAQ Biotechnology 100 Index
  List of companies with homepage and stock quote links.
• One-stop access to U.S. Government avian and pandemic flu information. Managed by the Department of Health and Human Services. http://www.pandemicflu.gov/ 
• NanoBiotech News is the first and only newsletter providing weekly intelligence, insider information, up-to-the-minute news and analysis, and online delivery.All Focused Squarely on the Emerging Nanobiotech Market!
• Nature Biotechnology - Presents scientific advances in life sciences. Includes a list of companies and an archive of published articles. Subscription required for full access.
• Recombinant Capital's biotech strategic alliance database
• Southwest Biotechnology and Informatics Center - Established to provide a single access point to resources for agricultural, pharmaceutical, and related fields.

Biotech Additional News

• CryoPort Updates Shareholders on Listing Status dated Jun 12, 2006 click here
• Aethlon Medical and Commonwealth Biotechnologies Sign Cooperative Research Agreement dated March 29, 2006 click here
• Aethlon Discloses CEO Interviews- Mr. Joyce discussed issues related to Avian Flu, including the potential use of the Aethlon Hemopurifier(TM) as a treatment countermeasure dated March 24, 2006 click here
• The Treatment of H5N1 Avian Influenza Report: Released by Aethlon Medical dated Mar 15, 2006 click here
• Bird Flu Oral Vaccine Licensed by MDM Group dated March 14, 2006 click here

Click Here For More

Biotech DVD's

Audio Interviews Exclusive Articles

 Audio Interviews

 Exclusive Articles

• Two Biotech Wizards Load up on Genomic Health - You’ve probably never heard of two hedge fund managers named Julian and Felix Baker -- because they keep a low profile. click here
• Cancer Drug IPO Sees Strong Insider Interest - Initial public offerings (IPOs) that see lots of insider buying as soon as they come out have been doing well, so let’s try another one. click here
• Potential Heart Attack Cure Could Reward Investors Big Time, posted July 6, 2006  - When doctor Mark Hyman is out promoting his popular book “Ultraprevention : The 6-Week Plan That Will Make You Healthy for Life,” he likes to point out that inflammation is the scourge behind many of the main ailments that do us in. click here
• Pharmaceutical industry - India, a giant in the making posted June 26, 2006 - A $10billion industry today, Indian pharma will grow to $25 billion by 2010.The country's drug sector had shown a growth of 10 percent compared with 7 percent for the global industry. click here
• China’s Fast Growing Economy- Industrialization, Consumption and the Quest for Resources - a discussion on how the world’s fastest growing economy impacts sectors including energy-renewable energy, water, coal-steel and healthcare. Participating companies XsunX, Inc. (OTCBB: XSNX), Vitasti, Inc. (OTCBB: VITSE), Hendrx Corp (OTCBB: HDRX), Puda Coal, Inc. (OTCBB: PUDC), and Bridgetech Holdings International, Inc. (OTC.PK: BGTH) provide insight from a first hand perspective of how smaller companies are feeling the impact and capitalizing on opportunities in China. click here

Click Here For More

Featured Articles By Industry Participants

• Can New Diabetic Research Replace the Edmonton Protocol? - Were it not for the Sertoli cell, none of us would ever have been born. It is the testicular Sertoli cell which keeps the human body's immune system from destroying a man's sperm. This same cell might create an immunologically protective environment for transplanted pancreas islets and could provide new hope for Type 1 diabetics whose bodies reject those transplants. click here
• Proteomics Market To Be A High Flyer - Many of the existing as well as start up pharmaceutical and biotechnology companies are under pressure to find and evolve new therapeutics at a minimum cost and within shorter time periods. At the same time they must make alternative and effective breakthroughs in introducing a new drug onto the market that would make a fair utility of the enormous costs involved. click here
• Pharmacogenomics: New Technologies in the Development of Personalized Therapies - The term Pharmacogenomics is evolved from the words pharmacology and genomics and therefore a combination of pharmaceuticals and genetics. Pharmacogenomics is a specialized study of how the genetic inheritance of an individual affects his bodys response to drugs. Being increasingly applied at the clinical level, its application is aimed on specific genes for therapeutics, and on screening genes for potential drug uses. It also aids pharmaceuticals in the development of highly sophisticated medications. click here
• Genomics Creates Opportunities in Drug Discovery Market - As budget for the pharmaceutical industry become constrained and lenient manufacturing gets more and more difficult the industry is pressed to develop drugs that comply with real value. The evolution of the drug discovery procedure and introduction of more efficient processes that deliver higher percentage at a quicker pace paves way to the genomics revolution. click here
• Inhaled Insulin: A New Modality for Management of Diabetes - Victimizing more than 194Mn people all over the world, diabetes has surfaced as one of the most fatal diseases known to man. As a consequence of growing cases of diabetes, innovative & effective therapeutic options are desperately needed by both medical fraternity and patients. click here

Click Here For More

Marketwire - Biotech

• DJohnson Holdings Acquires Control of 15% of the Shares of MIGENIX Inc. and Intends to Seek Board and Management Changes (Thu, 03 Jul 2008 20:17:00 EDT)  VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 3, 2008) - DJohnson Holdings Inc. (the "Company") announces that it acquired voting control and direction over 9,003,400 common shares of MIGENIX Inc. ("MIGENIX"). The Company now has beneficial ownership of and/or voting control and direction over an aggregate of 14,042,400 common shares (the "Shares"), representing approximately 15% of the total issued and outstanding common shares of MIGENIX. In the Company's view, the current board and management team have consistently failed to act in the best interests of shareholders and have lost credibility through their chronic failure to achieve their stated goals. To date, no product candidate developed by MIGENIX has been approved to be marketed commercially and MIGENIX has been unprofitable since its formation, incurring significant operating losses each year and incurring a cumulative deficit of $124.7 million to April 30, 2007. Largely under the stewardship of the present board and mana
• Xechem International Announces Conference Call to Address Information Update (Thu, 03 Jul 2008 16:35:00 EDT)  

  EDISON, NJ--(Marketwire - July 3, 2008) - Xechem International (PINKSHEETS: XKEM) today announced today that it will be holding a conference call to update shareholders and other interested persons on its business operations and financial status. Details for the call are:

  Date: July 10, 2008
  To: 9:30 a.m. Central Daylight Time
  Dial-In: Domestic: 1-866-548-2692
  International: 904-596-2360 - Outside the U.S. & Canada
  

• Dr. Eamonn Quigley Reveals Crucial Health Benefits of Taking Probiotics (Thu, 03 Jul 2008 15:49:00 EDT)  

  In His New Best-Selling Book, "Probiotics and Digestive Health: A Gastroenterologist's Perspective," Dr. Quigley Describes the Role of Beneficial Bacteria in Treating the Symptoms of IBS and Other Debilitating GI Problems

Biotech Funds and Venture Capital Investing

• American Biotech
• Biotech.about.com/library/bl_investing.htm
• Biotechnologyinvesting.com
• Biotechinvestingresource.com
• ICON Healthcare Fund (ICHCX) - Invests in the Healthcare sector in areas such as Biotechnology, Health Care Distributors, Health Care Equipment, Health Care, Facilities, Health Care Services, Health Care Supplies, Managed Health Care, and Pharmaceuticals.
• Investing-news.net/investing/investing-in-biotech-stocks.shtml
• Fool.com/news/indepth/biotech.htm
• Homeland Security Investment Banking - ProFinance(tm) Associates, Inc.: an investment banking firm headquartered in San Diego, provides M & A and financing advisory services to companies in high gross margin, repetitive income service industries, and to specialty finance companies. The electronic security industry has been an area of specialization for ProFinance since its inception in 1985. ProFinance is the originator and Michael is Chair of the Securing New Ground(tm) conference (www.securingnewground.com), the leading information and networking conference focused on the electronic security field in the U.S. ProFinance is also the originator and Michael is Chair of The Security Network (www.thesecuritynetwork.org), a San Diego-based organization to promote the San Diego region as a Center of Excellence for the development of dual usage security technologies and to become a national forum for collaborative work in the security field. Michael B. Jones, President, ProFinance Associates, Inc. (click here)
• Trading-report.com/stocks/top-biotech-stock.html
  

Biotech Industry Experts and Analysts

• Sharon Seiler, Senior Biotechnology Analyst, Punk, Ziegel & Company (http://www.pzk.com/ )

Biotech News Sources

Biotech Stock Indices

• CBN Stock Index:  Canadian Biotech News tracks the stock prices of all publicly listed companies involved in the biotechnology industry in Canada. Our Index however is composed of therapeutic and diagnostics companies whose stock price in the quarter ranges above $1.00. The CBN Index is an average of these prices added to a starting baseline of 100.
• AMEX Biotechnology Index (BTK) The Biotechnology Index is designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Click here for current quotes of index components
• NASDAQ Biotechnology Index includes securities of Nasdaq-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology. click here
• S&P Sector Indices Brochure

Biotech Industry Associations

• AusBiotech is the national body of companies and individuals dedicated to the development and prosperity of the Australian biotechnology industry. (more info)
• BayBio is Northern California's bioscience association that supports the regional bioscience community through networking, advocacy, group purchasing, and communicating the impact of our industry on the community. (more info)
• BIO -  Biotechnology Industry Association BioIndustry (BIA)
  The BioIndustry Association (BIA) http://www.bioindustry.org/ is the trade association for innovative enterprises in the UK's bioscience sector. (more info)
• BIOTECanada represents biotechnology companies and researchers in Canada. This site explains biotechnology and how it improves quality of life. (more info)
• Council for Biotechnology Information http://www.whybiotech.com/ The Council for Biotechnology Information communicates science-based information about the benefits and safety of agricultural and food biotechnology. Its members are the leading biotechnology companies and trade associations. (more info)
• The European Federation of Biotechnology is the non-profit association of all national and cross-national Learned Societies, Universities, Institutes, Companies and Individuals interested in the promotion of Biotechnology throughout Europe and beyond. (more info)
• The Security Network - The mission of The Security Network is to advance U.S. security by "Fostering Innovation Through Collaboration" on a national level. The non-profit, non-partisan Security Network will promote rapid commercialization of dual usage security technologies and development of effective regional security. (more info)
• The National Center for Biotechnology Information (NCBI) provides an integrated approach to the use of gene and protein sequence information, the scientific literature (MEDLINE), molecular structures, and related resources, in biomedicine. (more info)

Biotech Stock and Industry Blogs

• The Biotech Stock Blog. News and analysis of Biotech stocks www.biotechstockblog.com.
• Biotech Blog. Important business and scientific trends and developments in the biotechnology industry biotechblog. 
  

↑ Grab this Headline Animatornimator

TOP